Publications (original articles or review articles) published in 2023 from OUS - Department of Gynaecological Oncology
23 publications found
FIGO staging of endometrial cancer: 2023
Int J Gynaecol Obstet, 162 (2), 383-394
DOI 10.1002/ijgo.14923, PubMed 37337978
FIGO staging of endometrial cancer: 2023
J Gynecol Oncol, 34 (5), e85
DOI 10.3802/jgo.2023.34.e85, PubMed 37593813
Social media ambassadors and collaboration with OncoAlert: a European Network of Young Gynae Oncologists study of comparative Twitter analysis of #ESGO2021 and #ESGO2022
Int J Gynecol Cancer, 33 (6), 964-970
DOI 10.1136/ijgc-2023-004371, PubMed 37130625
Translation and cross-cultural adaptation of the Gynecologic Cancer Lymphedema Questionnaire and the Lower Extremity Lymphedema Screening Questionnaire
Int J Gynecol Cancer, 33 (2), 231-235
DOI 10.1136/ijgc-2022-003979, PubMed 36600491
Self-reported lower extremity lymphedema and quality of life after surgical staging of endometrial carcinoma: A population based cross-sectional study
Gynecol Oncol, 175, 72-80
DOI 10.1016/j.ygyno.2023.05.070, PubMed 37327542
Survival and modelled cancer antigen-125 ELIMination rate constant K score in ovarian cancer patients in first-line before poly(ADP-ribose) polymerase inhibitor era: A Gynaecologic Cancer Intergroup meta-analysis
Eur J Cancer, 191, 112966
DOI 10.1016/j.ejca.2023.112966, PubMed 37542936
Lymphovascular invasion and p16 expression are independent prognostic factors in stage I vulvar squamous cell carcinoma
Virchows Arch (in press)
DOI 10.1007/s00428-023-03670-y, PubMed 37843640
Cancer Stem Cell Markers Are Differentially Expressed in Malignant Ovarian Germ Cell Tumors
Int J Gynecol Pathol, 42 (6), 613-619
DOI 10.1097/PGP.0000000000000947, PubMed 37186896
Occludin is overexpressed in tubo-ovarian high-grade serous carcinoma compared to mesothelioma and is a marker of tumor progression and chemoresistance
Clin Exp Metastasis, 41 (1), 69-76
DOI 10.1007/s10585-023-10251-5, PubMed 38141113
Clinical significance of L1CAM expression in metastatic tubo-ovarian high-grade serous carcinoma
Gynecol Oncol, 176, 76-81
DOI 10.1016/j.ygyno.2023.07.004, PubMed 37478615
Characterization of ovarian cancer survival by histotype and stage: A nationwide study in Norway
Int J Cancer, 153 (5), 969-978
DOI 10.1002/ijc.34576, PubMed 37226635
Surgery for Recurrent Epithelial Ovarian Cancer
Curr Oncol Rep, 26 (1), 46-54
DOI 10.1007/s11912-023-01480-8, PubMed 38091202
Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer
Clin Cancer Res, 29 (20), 4068-4075
DOI 10.1158/1078-0432.CCR-23-0621, PubMed 37581616
European multidisciplinary tumor boards support cross-border networking and increase treatment options for patients with rare gynecological tumors
Int J Gynecol Cancer, 33 (10), 1621-1626
DOI 10.1136/ijgc-2023-004599, PubMed 37783481
CA-125 Early Dynamics to Predict Overall Survival in Women with Newly Diagnosed Advanced Ovarian Cancer Based on Meta-Analysis Data
Cancers (Basel), 15 (6)
DOI 10.3390/cancers15061823, PubMed 36980708
Patient-reported nausea after implementation of an enhanced recovery after surgery protocol for gynae-oncology patients
Int J Gynecol Cancer, 33 (8), 1287-1294
DOI 10.1136/ijgc-2023-004356, PubMed 37451689
Prospective evaluation of an enhanced recovery after surgery (ERAS) pathway in a Norwegian cohort of patients with suspected or advanced ovarian cancer
Int J Gynecol Cancer, 33 (8), 1279-1286
DOI 10.1136/ijgc-2023-004355, PubMed 37451690
Risk factors for the increasing incidence of pregnancy-associated cancer in Sweden - a population-based study
Acta Obstet Gynecol Scand, 103 (4), 669-683
DOI 10.1111/aogs.14677, PubMed 37694965
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial
Lancet, 403 (10421), 31-43
DOI 10.1016/S0140-6736(23)02405-4, PubMed 38048793
Associations between modifiable lifestyle factors and health-related quality of life among endometrial carcinoma survivors - A cross-sectional study
Gynecol Oncol, 179, 52-62
DOI 10.1016/j.ygyno.2023.10.012, PubMed 37924595
Self-reported distress and problems after treatment for gynecological cancer - Correlation between a short screening tool and longer measures of anxiety/depression and health-related quality of life
Acta Obstet Gynecol Scand, 103 (2), 387-395
DOI 10.1111/aogs.14709, PubMed 37991142
Pelvic exenteration for vulvar cancer: Postoperative morbidity and oncologic outcome - A single center retrospective analysis
Eur J Surg Oncol, 49 (9), 106958
DOI 10.1016/j.ejso.2023.06.010, PubMed 37349160
Real-world data on niraparib maintenance treatment in patients with non-gBRCA mutated platinum-sensitive recurrent ovarian cancer
Int J Gynecol Cancer, 33 (12), 1898-1905
DOI 10.1136/ijgc-2023-004484, PubMed 38000795